Sharath Burugina Nagaraja
Overview
Explore the profile of Sharath Burugina Nagaraja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Amponsah O, Nagaraja S, Ayisi-Boateng N, Nair D, Muradyan K, Asense P, et al.
Int J Environ Res Public Health
. 2022 Aug;
19(16).
PMID: 36011917
Background: Monitoring of antibiotic prescription practices in hospitals is essential to assess and facilitate appropriate use. This is relevant to halt the progression of antimicrobial resistance. Methods: Assessment of antibiotic...
12.
Tejashree A, Mahesh P, Krishna Karthik M, Nirmala , Azeem A, Reddy R, et al.
Indian J Tuberc
. 2022 Jan;
69(1):79-84.
PMID: 35074155
Introduction: The mycobacterium tuberculosis complex (MTBC) has highly clonal population structure which made the organism spread globally mirroring human migration out of Africa and resulted in the formation of seven...
13.
Nagaraja S, Thekkur P, Satyanarayana S, Tharyan P, Sagili K, Tonsing J, et al.
Trop Med Infect Dis
. 2021 Dec;
6(4).
PMID: 34941662
India launched a national community-based active TB case finding (ACF) campaign in 2017 as part of the strategic plan of the National Tuberculosis Elimination Programme (NTEP). This review evaluated the...
14.
Chawla K, Nagaraja S, Siddalingaiah N, Sanju C, Shenoy V, Kumar U, et al.
Trop Med Infect Dis
. 2021 Sep;
6(3).
PMID: 34564551
In India, challenges in pediatric TB contact screening and chemoprophylaxis initiation are still underexplored. Elucidating these challenges will help in better implementation of the programme at the grass-roots level thereby...
15.
Acharya M, Pradeep S, Murthy V, Chikkannaiah P, Kambar V, Narayanashetty S, et al.
Clin Infect Dis
. 2021 Sep;
73(5):793-801.
PMID: 34492697
Background: Early and accurate diagnosis followed by timely treatment are the key prerequisites to fight tuberculosis (TB) and reduce its global burden. Despite scientific advances, the rapid and correct diagnosis...
16.
Kelamane S, Satyanarayana S, Nagaraja S, Panibatla V, Dasari R, Rajeesham , et al.
Tuberc Res Treat
. 2021 Jul;
2021:9579167.
PMID: 34239728
Background: Informal (unqualified) health care providers are an important source of medical care for persons with presumptive TB (PPTB) in India. A project (titled RIPEND) was implemented to engage informal...
17.
Shewade H, Nagaraja S, Murthy H, Vanitha B, Bhargava M, Singarajipura A, et al.
Trop Med Infect Dis
. 2021 Jul;
6(2).
PMID: 34203984
Due to limited availability of diagnostics and capacity, people with tuberculosis do not always undergo systematic assessment for severe illness (requiring inpatient care). In Karnataka (south India), para-medical programme staff...
18.
Marimuthu Y, Kunnavil R, Anil N, Nagaraja S, Satyanarayana N, Kumar J, et al.
Monaldi Arch Chest Dis
. 2021 May;
91(3).
PMID: 34006039
COVID-19 is an emerging viral disease affecting more than 200 countries worldwide and it present with varied clinical profile throughout the world. Without effective drugs to cure COVID-19, early identification...
19.
Nagaraja S, Kelamane S, Kunjathur S, Gurram Krishnamurthy S
Indian J Tuberc
. 2021 Apr;
68(2):283-284.
PMID: 33845967
No abstract available.
20.
Ranganath R, Shewade H, Bahadur A, Naik V, Nagaraja S, Kumar A, et al.
Trans R Soc Trop Med Hyg
. 2021 Apr;
116(1):43-49.
PMID: 33823556
Background: India implements universal drug susceptibility testing (UDST) using rapid genotypic tests (cartridge-based nucleic acid amplification test CBNAAT - and line probe assay - LPA). to bridge the gap of...